Archived Insight | March 16, 2023

End of COVID-19 Emergencies: Impact on Plan Sponsors

On January 30, 2023, the Biden Administration announced it would end both the public health emergency (PHE) and national emergency (NE) related to COVID-19 effective May 11, 2023. As healthcare costs related to COVID-19 begin to transition, plan sponsors will need to make decisions whether to continue to allow coverage and flexibility under the PHE and NE rules, go back to pre-COVID-19 rules or compromise somewhere in the middle.

End of COVID-19 Emergencies and the Impact to Plan Sponsors and Participants

In this webinar...

Our experts discussed the considerations for plan sponsors and provided data and additional details to help determine the best path forward, including:

  • The emergency ending and what that transition means for health plans
  • COVID-19 costs and the transition impact to plan sponsors and participants
  • Communication requirements and best practices to keep participants informed

Webinar Replay

 

Speakers

Kathryn Bakich, Senior Vice President, Health Compliance Practice Leader
Jason Jossie, Senior Health Consultant
Angela Purdum, Vice President, Communications

Get the Slides

Don’t have time to watch a video right now? No worries. Here is a copy of the slides from this session.

Download Now

See more insights

Asian Female Pharmacist Uses Computer To Check Inventory For A Drug

Designing and Negotiating Affordable Pharmacy Benefits

Learn how health plan sponsors can improve pharmacy benefit value through PBM contracting, formulary management and clinical oversight.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Pharmaceutical, Healthcare Cost Management

Read Full Insight

Man Self Injecting GLP 1 Weight Loss Medication Pen At Home

GLP-1s Have Disrupted the Market for Other Diabetes Drugs

Segal’s SHAPE data shows how rising GLP-1 use coincided with declines in insulin, Metformin and DPP-4 inhibitor use.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Pharmaceutical

Read Full Insight

Femal Japanese Professor Standing Next To Student Teaching

2026 College and University Benefits Study

See how your institution’s benefits compare with peers and use 2026 CUBS benchmarking data and insights to strengthen total rewards strategy now.

Benefits Administration, Benefits Technology, Higher Education, Retirement, Pharmaceutical, Health, Communications

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.